▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2745 by analyst upside · 2026-06-27
BLFS
BioLife Solutions, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+12.7%
implied upside to consensus target
Current Price $28.67
Consensus Target $32.3
Bull Target $34.0
Bear Target $30.0
Analysts Covering 10
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
9
Hold
0
Sell
0
52-Week Low $17.86
52-Week High $29.81
YTD Return +20.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E 98.9x
EPS (TTM) $-0.24
PEG Ratio 15.09
Dividend Yield N/A
Revenue (TTM) $102M
Profit Margin -2.9%
52-WEEK RANGE
52-Week Low $17.86
52-Week High $29.81
Current Price $28.67
Bear Target $30.0
Bull Target $34.0
● Now $28.67 ● Target $32.3
TRADING DATA
Avg Volume 586K
YTD Return +20.0%
Analyst Count 10
Consensus Buy
Upside to Target +12.7%
Last Updated 2026-06-27

ANALYST SUMMARY

BioLife Solutions, Inc. (BLFS) is currently trading at $28.67 with a Wall Street consensus price target of $32.3, implying potential upside of 12.7% over the next 12 months. 10 analysts currently cover BLFS, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $34.0, while the most cautious has a target of $30.0.

BLFS operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 20.0% year-to-date and is currently trading near the upper end of its 52-week range of $17.86 – $29.81.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CNMD +10.2%
CONMED Corporation
$1B · P/E 19.5x · Hold
HCSG +7.8%
Healthcare Services Group, Inc.
$2B · P/E 24.8x · Hold
UFPT +24.9%
UFP Technologies, Inc.
$2B · P/E 29.6x · Underperform
PNTG +13.7%
The Pennant Group, Inc.
$1B · P/E 41.8x · Buy
PAHC +43.9%
Phibro Animal Health Corporation
$1B · P/E 13.7x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for BLFS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2025-12-29 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-11-24 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-08-08 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-05-13 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-03-06 31% win rate (48 calls)
Northland Capital Markets — Reiterated
Outperform → Outperform 2025-01-08 Building track record
Benchmark reit
Buy → Buy 2024-12-19 Building track record
Keybanc — Reiterated
Overweight → Overweight 2024-12-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →